BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16327877)

  • 21. Ziprasidone ameliorates anxiety-like behaviors in a rat model of PTSD and up-regulates neurogenesis in the hippocampus and hippocampus-derived neural stem cells.
    Peng Z; Zhang R; Wang H; Chen Y; Xue F; Wang L; Yang F; Chen Y; Liu L; Kuang F; Tan Q
    Behav Brain Res; 2013 May; 244():1-8. PubMed ID: 23384713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ziprasidone in the treatment of delayed carbon monoxide encephalopathy.
    Hu MC; Shiah IS; Yeh CB; Chen HK; Chen CK
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):755-7. PubMed ID: 16581170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
    Zink M; Kuwilsky A; Krumm B; Dressing H
    J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe withdrawal symptoms after discontinuation of alprazolam in eight patients with combat-induced posttraumatic stress disorder.
    Risse SC; Whitters A; Burke J; Chen S; Scurfield RM; Raskind MA
    J Clin Psychiatry; 1990 May; 51(5):206-9. PubMed ID: 2335496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inositol treatment of post-traumatic stress disorder.
    Kaplan Z; Amir M; Swartz M; Levine J
    Anxiety; 1996; 2(1):51-2. PubMed ID: 9160600
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of drug-induced psychosis in Parkinson's disease with ziprasidone can induce severe dose-dependent off-periods and pathological laughing.
    Schindehütte J; Trenkwalder C
    Clin Neurol Neurosurg; 2007 Feb; 109(2):188-91. PubMed ID: 16949733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjunctive aripiprazole in combat-related posttraumatic stress disorder.
    Padala PR; List D; Petty F; Bhatia SC
    Ann Pharmacother; 2007 Oct; 41(10):1744. PubMed ID: 17848426
    [No Abstract]   [Full Text] [Related]  

  • 28. Exacerbation of PTSD symptoms with use of duloxetine.
    Deneys ML; Ahearn EP
    J Clin Psychiatry; 2006 Mar; 67(3):496-7. PubMed ID: 16649841
    [No Abstract]   [Full Text] [Related]  

  • 29. [Ziprasidone as coadjuvant treatment in resistant obsessive-compulsive disorder treatment].
    Iglesias Garcia C; Santamarina Montila S; Alonso Villa MJ
    Actas Esp Psiquiatr; 2006; 34(4):277-9. PubMed ID: 16823689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ziprasidone- and lithium-induced neuroleptic malignant syndrome.
    Borovicka MC; Bond LC; Gaughan KM
    Ann Pharmacother; 2006 Jan; 40(1):139-42. PubMed ID: 16352776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of sildenafil citrate in treating erectile dysfunction in patients with combat-related post-traumatic stress disorder: a double-blind, randomized and placebo-controlled study.
    Safarinejad MR; Kolahi AA; Ghaedi G
    BJU Int; 2009 Aug; 104(3):376-83. PubMed ID: 19389004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ziprasidone-associated depressive state in schizophrenic patients.
    Kaptsan A; Dwolatzky T; Lerner V
    Clin Neuropharmacol; 2007; 30(6):357-61. PubMed ID: 18090461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness, safety, and tolerability of ziprasidone for treating schizophrenia patients undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
    Ratner Y; Gibel A; Yorkov V; Ritsner MS
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1401-9. PubMed ID: 17669574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ziprasidone for drug-induced psychotic symptoms in Parkinson's Disease.
    Duggal HS; Singh I
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):583-4. PubMed ID: 18022304
    [No Abstract]   [Full Text] [Related]  

  • 35. Ziprasidone-associated pedal edema in the treatment of schizophrenia.
    Ku HL; Su TP; Chou YH
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):963-4. PubMed ID: 16624468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychostimulant treatment of combat-related posttraumatic stress disorder.
    Houlihan DJ
    J Psychopharmacol; 2011 Nov; 25(11):1568-72. PubMed ID: 20935024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population.
    Davis LL; Davidson JR; Ward LC; Bartolucci A; Bowden CL; Petty F
    J Clin Psychopharmacol; 2008 Feb; 28(1):84-8. PubMed ID: 18204347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ziprasidone-induced tardive laryngeal dystonia: a case report.
    Tsai CS; Lee Y; Chang YY; Lin PY
    Gen Hosp Psychiatry; 2008; 30(3):277-9. PubMed ID: 18433661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A qualitative investigation of long-term zopiclone use and sleep quality among Vietnam war veterans with PTSD.
    Alderman CP; Gilbert AL
    Ann Pharmacother; 2009 Oct; 43(10):1576-82. PubMed ID: 19706738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An open-label study of mirtazapine as treatment for combat-related PTSD.
    Alderman CP; Condon JT; Gilbert AL
    Ann Pharmacother; 2009 Jul; 43(7):1220-6. PubMed ID: 19584388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.